Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung Cancer
Clinical trial NCT03396497 · UNKNOWN
Trial details
- NCT number
- NCT03396497
- Sponsor
- Lycera Corp.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-03
- Primary completion
- 2019-10-20
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.